Alembic Therapeutics draws upon the rich heritage of Alembic Pharma to deliver advanced health solutions. With integrated capabilities in research, development, manufacturing and marketing, it focuses on bringing high-quality pharmaceutical innovations to market. Its global footprint, regulatory compliance and commitment to patient access enable it to serve diverse therapeutic areas while ensuring the highest standards of safety and efficacy.
Since its founding roots in Vadodara over a century ago, Alembic has evolved into a research-driven pharmaceutical leader. It emphasizes scientific excellence, ethical operations and sustainability. Clinical research teams and regulatory affairs specialists collaborate to expand its product pipeline, while modern manufacturing plants maintain quality across domestic and export lines. The company culture fosters continuous learning, innovation and alignment with global healthcare needs.
Alembic Therapeutics offers a diversified portfolio spanning generics, specialty formulations, and APIs. Its product portfolio addresses key therapeutic areas such as anti-infectives, cardiology, dermatology, nephrology and more. Each product is developed to meet stringent global regulatory standards, backed by robust clinical evidence and quality assurance measures. The pipeline includes both established products and newer developments under clinical evaluation.
Partnering is central to Alembic’s strategy for accelerating innovation and expanding market reach. The company collaborates with academic institutions, biotech firms, licensing partners and contract research organizations to co-develop novel therapies, share scientific expertise and leverage distribution networks. Such alliances enable faster access to new technologies, better resource utilization and entry into new geographies.
At Alembic Therapeutics, career growth is built on curiosity, capability and contribution. Professionals in R&D, quality assurance, regulatory affairs, manufacturing, supply chain and commercialization find opportunities to participate in meaningful projects that impact patient care. The organization invests in training, leadership development and cross-functional exposure to nurture talent in a dynamic environment.
Alembic Therapeutics is committed to ensuring patients have affordable and consistent access to prescribed medications. Through copay support programs, eligible patients can receive financial assistance to reduce out-of-pocket costs and continue their treatment without interruption. The program is designed to make therapies more accessible, alleviate financial barriers, and improve adherence to prescribed regimens. Patients, caregivers, and healthcare providers can learn more about enrollment, eligibility requirements, and resources available to support ongoing treatment needs.
The safety of patients is a core commitment. Reporting adverse events plays a critical role in monitoring product performance and safeguarding public health. Users experiencing unexpected effects or side effects from an Alembic product are encouraged to share as many details as possible—such as dosage, duration, symptoms, outcomes and concomitant medications. Each report contributes to pharmacovigilance efforts, enabling continuous assessment and improved risk management across the product line.
Alembic Therapeutics welcomes dialogue with patients, healthcare providers, researchers and business partners. Whether you have inquiries about product information, collaboration opportunities, regulatory affairs, or support services, you can reach out via email, phone or the contact form. The team strives for prompt, clear and professional responses to facilitate effective communication.
50 Hills Drive, Suite 110, Bedminster, NJ, 07921, USA